Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Evrysdi® (risdiplam) – Expanded indication
May 30, 2022 - Roche announced the FDA approval of Evrysdi (risdiplam), for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.
